Carlsmed, Inc. (CARL)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	32.27M
Net Income (ttm)	-25.72M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CARL

Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. We are focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of artificial intelligence-enabled software solutions, and interbody implants that we custom design for each patient’s unique pathology and vertebral bone topography, and single-use surgical instruments (the “aprevo Te...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2018
• Employees: 100
• Stock Exchange: NASDAQ
• Ticker Symbol: CARL
• Website: https://carlsmed.com/

Financial Performance

Financial numbers in USD